|
|
 |
|
e-commerce,cnn,money |
| E-commerce |
 |
 |
CNN Money
Decoding the Fed's confusing message
Interest rates are set to rise next week. That much we know.
Buffett solves his cash crisis
If every year you had more cash than the year before, would you have a problem with that? If every year you had a lot more cash than the year before, would you have a problem with that? And if, at last count, your cash had piled up to $37 billion, would you have a problem with that?
Living in a real estate dead zone
The stories keep piling up. In many once-sizzling markets around the country, accounts of dropping list prices have replaced tales of waiting lists for unbuilt condos and bidding wars over humdrum three-bedroom colonials.
A car that could save the planet--fast
Ian Wright has a car that blows away a Ferrari 360 Spider and a Porsche Carrera GT in drag races, and whose 0-to-60 acceleration time ranks it among the fastest production autos in the world. In fact, it's second only to the French-made Bugatti Veyron, a 1,000-horsepower, 16-cylinder beast that hits 60 mph half a second faster and goes for $1.25 million.
3 IPOs set for week ahead
The IPO calendar looks fairly light this week, with investment bankers aiming to raise about $421 million.
Sony's other units depend on the PS3's success
TOKYO, May 7 (Reuters) - With the launch of its PlayStation 3 video game console six months away, Sony Corp. is gearing up for an all-out battle to put the electronics and entertainment conglomerate back on a growth path.
Japan, U.S. to develop supersonic aircraft
TOKYO, May 7 (Reuters) - The Japan Aerospace Exploration Agency and several Japanese firms will launch a joint project with the National Aeronautics and Space Administration and Boeing Co. of the United States to develop a next-generation supersonic passenger aircraft, business daily Nihon Keizai Shimbun reported on Sunday.
Paper: Pfizer's Nigeria drug test illegal
WASHINGTON, May 6 (Reuters) - Nigerian medical experts concluded Pfizer Inc. violated international law during a 1996 epidemic by testing an unapproved drug on children with brain infections, the Washington Post reported in Sunday editions, citing a copy of the panel's confidential report.
|
|
|
 |
|
|
|
